dc.contributor.author | Cruz R.H.B. | |
dc.contributor.author | Sanchez M.M. | |
dc.contributor.author | Dominguez-Sanchez M.A. | |
dc.contributor.author | Barreto G.E. | |
dc.contributor.author | Lancheros D. | |
dc.contributor.author | Reynolds J. | |
dc.date.accessioned | 2020-09-02T22:16:06Z | |
dc.date.available | 2020-09-02T22:16:06Z | |
dc.date.issued | 2017 | |
dc.identifier | 10.2174/1381612823666170816115452 | |
dc.identifier.citation | 23, 28, 4154-4169 | |
dc.identifier.issn | 13816128 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/4196 | |
dc.description | The use of nanotechnology in neurosciences has been evolving since new treatments, diagnoses and biomolecule monitoring are needed to find safer treatments for central nervous system diseases (CNDs). Nanotechnology employs devices that interact with biological systems allowing molecular interactions with a high degree of specificity. This review considers concepts associated with nanotechnology and leading areas of neurosciences with nanotechnology research. © 2017 Bentham Science Publishers. | |
dc.language.iso | en | |
dc.publisher | Bentham Science Publishers B.V. | |
dc.subject | Biosensors | |
dc.subject | Glial cells | |
dc.subject | Nanosensors | |
dc.subject | Nanotechnology | |
dc.subject | Neuroregeneration | |
dc.subject | Neurosciences | |
dc.subject | nanomaterial | |
dc.subject | nanoparticle | |
dc.subject | central nervous system agents | |
dc.subject | bioengineering | |
dc.subject | central nervous system disease | |
dc.subject | clinical assessment tool | |
dc.subject | electrochemical detection | |
dc.subject | fluorescence imaging | |
dc.subject | glia cell | |
dc.subject | human | |
dc.subject | molecular interaction | |
dc.subject | molecular mechanics | |
dc.subject | nanotechnology | |
dc.subject | nerve regeneration | |
dc.subject | neurobiology | |
dc.subject | neuroimaging | |
dc.subject | neuropharmacology | |
dc.subject | neuroscience | |
dc.subject | nonhuman | |
dc.subject | nuclear magnetic resonance imaging | |
dc.subject | piezoelectricity | |
dc.subject | positron emission tomography | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | single photon emission computed tomography | |
dc.subject | animal | |
dc.subject | central nervous system disease | |
dc.subject | drug delivery system | |
dc.subject | drug design | |
dc.subject | nanotechnology | |
dc.subject | procedures | |
dc.subject | Animals | |
dc.subject | Central Nervous System Agents | |
dc.subject | Central Nervous System Diseases | |
dc.subject | Drug Delivery Systems | |
dc.subject | Drug Design | |
dc.subject | Humans | |
dc.subject | Nanotechnology | |
dc.title | Nanotechnology in neurosciences: An approach | |
dc.type | Review | |